Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

Published:2012-11-30 Issue:11 Volume:7 Page:e48787
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bhatia Shailender,Moon James,Margolin Kim A.,Weber Jeffrey S.,Lao Christopher D.,Othus Megan,Aparicio Ana M.,Ribas Antoni,Sondak Vernon K.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society;AE Chang;Cancer,1998

2. Incidence of noncutaneous melanomas in the U.S;CC McLaughlin;Cancer,2005

3. Uveal melanoma: trends in incidence, treatment, and survival;AD Singh;Ophthalmology,2011

4. Very long-term prognosis of patients with malignant uveal melanoma;E Kujala;Invest Ophthalmol Vis Sci,2003

5. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26;M Diener-West;Arch Ophthalmol,2005

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current therapeutic strategies for the treatment of ocular melanoma;Onkologie;2024-06-24

2. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

3. Updates in the Management of Uveal Melanoma;The Cancer Journal;2024-03

4. Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior;Investigative Opthalmology & Visual Science;2024-02-21

5. Ocular Surface Side Effects of Novel Anticancer Drugs;Cancers;2024-01-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3